Found: 106
Select item for more details and to access through your institution.
Physical, Psychological, and Cognitive Profile of Post-COVID Conditions in Healthcare Workers, Quebec, Canada.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 8, p. 1, doi. 10.1093/ofid/ofac386
- By:
- Publication type:
- Article
SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 5, p. 1, doi. 10.1093/ofid/ofac178
- By:
- Publication type:
- Article
Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness?
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 9, p. N.PAG, doi. 10.1093/ofid/ofy211
- By:
- Publication type:
- Article
Other Respiratory Viruses Are Important Contributors to Adult Respiratory Hospitalizations and Mortality Even During Peak Weeks of the Influenza Season.
- Published in:
- Open Forum Infectious Diseases, 2014, v. 1, n. 2, p. 1, doi. 10.1093/ofid/ofu086
- By:
- Publication type:
- Article
Avian Influenza A(H7N9) Virus Infection in 2 Travelers Returning from China to Canada, January 2015.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Seroconversion to seasonal influenza viruses after A(H1N1)pdm09 virus infection, Quebec, Canada.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Seroconversion to Seasonal Influenza Viruses after A(H1N1) pdm09 Virus Infection, Quebec, Canada.
- Published in:
- Emerging Infectious Diseases, 2012, v. 18, n. 7, p. 1132, doi. 10.3201/eid1807.111680
- By:
- Publication type:
- Article
2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN).
- Published in:
- Eurosurveillance (15607917), 2024, v. 29, n. 7, p. 1, doi. 10.2807/1560-7917.ES.2024.29.7.2400076
- By:
- Publication type:
- Article
Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23.
- Published in:
- Eurosurveillance (15607917), 2023, v. 28, n. 5, p. 10, doi. 10.2807/1560-7917.ES.2023.28.5.2300043
- By:
- Publication type:
- Article
Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada.
- Published in:
- Eurosurveillance (15607917), 2022, v. 27, n. 38, p. 2, doi. 10.2807/1560-7917.ES.2022.27.38.2200720
- By:
- Publication type:
- Article
Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020.
- Published in:
- Eurosurveillance (15607917), 2020, v. 25, n. 7, p. 2, doi. 10.2807/1560-7917.es.2020.25.7.2000103
- By:
- Publication type:
- Article
Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).
- Published in:
- Eurosurveillance (15607917), 2019, v. 24, n. 46, p. 1, doi. 10.2807/1560-7917.ES.2019.24.46.1900585
- By:
- Publication type:
- Article
Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: possible cohort effect following the 2009 influenza pandemic.
- Published in:
- Eurosurveillance (15607917), 2019, v. 24, n. 15, p. 32, doi. 10.2807/1560-7917.ES.2019.24.15.1900104
- By:
- Publication type:
- Article
Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019.
- Published in:
- Eurosurveillance (15607917), 2019, v. 24, n. 4, p. 6, doi. 10.2807/1560-7917.ES.2019.24.4.1900055
- By:
- Publication type:
- Article
Aggregate content influences the Th1/Th2 immune response to influenza vaccine: Evidence from a mouse model.
- Published in:
- Journal of Medical Virology, 2004, v. 72, n. 1, p. 138
- By:
- Publication type:
- Article
Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.836449
- By:
- Publication type:
- Article
Coordinated Response to SARS, Vancouver, Canada.
- Published in:
- Emerging Infectious Diseases, 2006, v. 12, n. 1, p. 155, doi. 10.3201/eid1201.050327
- By:
- Publication type:
- Article
Modeling Control Strategies of Respiratory Pathogens.
- Published in:
- Emerging Infectious Diseases, 2005, v. 11, n. 8, p. 1249, doi. 10.3201/eid1108.040449
- By:
- Publication type:
- Article
Novel Avian Influenza H7N3 Strain Outbreak, British Columbia.
- Published in:
- Emerging Infectious Diseases, 2004, v. 10, n. 12, p. 2192, doi. 10.3201/eid1012.040743
- By:
- Publication type:
- Article
Human Illness from Avian Influenza H7N3, British Columbia.
- Published in:
- Emerging Infectious Diseases, 2004, v. 10, n. 12, p. 2196, doi. 10.3201/eid1012.040961
- By:
- Publication type:
- Article
Human Illness and Isolation of Low-Pathogenicity Avian Influenza Virus of the H7N3 Subtype in British Columbia, Canada.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Does Antigen-Specific Cytokine Response Correlate with the Experience of Oculorespiratory Syndrome after Influenza Vaccine?
- Published in:
- Journal of Infectious Diseases, 2003, v. 187, n. 3, p. 495, doi. 10.1086/368117
- By:
- Publication type:
- Article
CORRESPONDENCE.
- Published in:
- 2002
- By:
- Publication type:
- Letter
The Changing Age and Seasonal Profile of Pertussis in Canada.
- Published in:
- Journal of Infectious Diseases, 2002, v. 185, n. 10, p. 1448, doi. 10.1086/340280
- By:
- Publication type:
- Article
Influenza Revaccination of Elderly Travelers: Antibody Response to Single Influenza Vaccination and Revaccination at 12 Weeks.
- Published in:
- Journal of Infectious Diseases, 2001, v. 184, n. 2, p. 188, doi. 10.1086/322013
- By:
- Publication type:
- Article
Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2023, v. 195, n. 42, p. E1427, doi. 10.1503/cmaj.230721
- By:
- Publication type:
- Article
Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2022, v. 194, n. 47, p. E1599, doi. 10.1503/cmaj.221335
- By:
- Publication type:
- Article
Previous infection with seasonal coronaviruses does not protect male Syrian hamsters from challenge with SARS-CoV-2.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41761-1
- By:
- Publication type:
- Article
Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.
- Published in:
- Eurosurveillance (15607917), 2018, v. 23, n. 5, p. 2, doi. 10.2807/1560-7917.ES.2018.23.5.18-00035
- By:
- Publication type:
- Article
Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0132195
- By:
- Publication type:
- Article
Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0092153
- By:
- Publication type:
- Article
Randomized Controlled Ferret Study to Assess the Direct Impact of 2008–09 Trivalent Inactivated Influenza Vaccine on A(H1N1)pdm09 Disease Risk.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086555
- By:
- Publication type:
- Article
H3N2v and Other Influenza Epidemic Risk Based on Age- Specific Estimates of Sero-Protection and Contact Network Interactions.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0054015
- By:
- Publication type:
- Article
Cross-Lineage Influenza B and Heterologous Influenza AAntibody Responses in Vaccinated Mice: ImmunologicInteractions and B/Yamagata Dominance.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0038929
- By:
- Publication type:
- Article
School Absenteeism As an Adjunct Surveillance Indicator: Experience during the Second Wave of the 2009 H1N1 Pandemic in Quebec, Canada.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0034084
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness in the Elderly Based on Administrative Databases: Change in Immunization Habit as a Marker for Bias.
- Published in:
- PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0022618
- By:
- Publication type:
- Article
Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
- Published in:
- Journal of Infectious Diseases, 2015, v. 212, n. 5, p. 726, doi. 10.1093/infdis/jiv177
- By:
- Publication type:
- Article
Pre- and Postpandemic Estimates of 2009 Pandemic Influenza A(H1N1) Seroprotection to Inform Surveillance-Based Incidence, by Age, During the 2013-2014 Epidemic in Canada.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Pre- and Postpandemic Estimates of 2009 Pandemic Influenza A(H1N1) Seroprotection to Inform Surveillance-Based Incidence, by Age, During the 2013–2014 Epidemic in Canada.
- Published in:
- Journal of Infectious Diseases, 2015, v. 211, n. 1, p. 109, doi. 10.1093/infdis/jiu366
- By:
- Publication type:
- Article
Influenza A/Subtype and B/Lineage Effectiveness Estimates for the 2011-2012 Trivalent Vaccine: Cross-Season and Cross-Lineage Protection With Unchanged Vaccine.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Largest Measles Epidemic in North America in a Decade—Quebec, Canada, 2011: Contribution of Susceptibility, Serendipity, and Superspreading Events.
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. 6, p. 990, doi. 10.1093/infdis/jis923
- By:
- Publication type:
- Article
Largest measles epidemic in north america in a decade--quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Cross-reactive and Vaccine-Induced Antibody to an Emerging Swine-Origin Variant of Influenza A Virus Subtype H3N2 (H3N2v).
- Published in:
- Journal of Infectious Diseases, 2012, v. 206, n. 12, p. 1852, doi. 10.1093/infdis/jis500
- By:
- Publication type:
- Article
Estimates of Influenza Vaccine Effectiveness for 2007–2008 From Canada's Sentinel Surveillance System: Cross-Protection Against Major and Minor Variants.
- Published in:
- Journal of Infectious Diseases, 2012, v. 205, n. 12, p. 1858, doi. 10.1093/infdis/jis283
- By:
- Publication type:
- Article
Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Immuno-epidemiologic Correlates of Pandemic H1N1 Surveillance Observations: Higher Antibody and Lower Cell-Mediated Immune Responses with Advanced Age.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. 2, p. 158, doi. 10.1093/infdis/jiq039
- By:
- Publication type:
- Article
Component-Specific Effectiveness of Trivalent Influenza Vaccine as Monitored through a Sentinel Surveillance Network in Canada, 2006-2007.
- Published in:
- Journal of Infectious Diseases, 2009, v. 199, n. 2, p. 168, doi. 10.1086/595862
- By:
- Publication type:
- Article
Rapid Decline of Influenza Vaccine—Induced Antibody in the Elderly Is It Real, or Is It Relevant?
- Published in:
- Journal of Infectious Diseases, 2008, v. 197, n. 4, p. 490, doi. 10.1086/524146
- By:
- Publication type:
- Article
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA–Vaccinated and Nonvaccinated Individuals in Quebec, Canada.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 10, p. e2236670, doi. 10.1001/jamanetworkopen.2022.36670
- By:
- Publication type:
- Article
RE: "DETECTABLE RISKS IN STUDIES OF THE FETAL BENEFITS OF MATERNAL INFLUENZA VACCINATION".
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor